ARTICLE SYNOPSIS...When Jim Cramer on "CNBC Squawk on the Street" says that he likes a stock, is it worth looking at?
ARTICLE SYNOPSIS...This stock is probably not on your radar screen yet. Maybe it should be.
ARTICLE SYNOPSIS...One of the worst performing sectors this past year has been the Health Care sector, and of its sub-sectors, Biotechnology was one of the poorest performers. Gilead Sciences (GILD), a component of that sub-sector lost about 21% over the past year, making
ARTICLE SYNOPSIS...A share to keep an eye on, but is it due for a correction?
ARTICLE SYNOPSIS...Gilead Sciences, Inc. (GILD) President and COO John Milligan sold 100,000 shares for $10.3 million on September 8, 2015. What does that suggest?
ARTICLE SYNOPSIS...Shares of Gilead Sciences, Inc. have been in a long-term bull market for several years, but warnings of a bearish trend reversal are now in place.